Sickle cell disease affects 100,000 people in the United States and far more internationally. One of the most dangerous manifestations of the disease is acute chest syndrome, which involves a vicious cycle of erythrocyte sickling and respiratory failure. Acute chest syndrome can be a presenting feature upon hospital admission, it can arise as a complication of a vasoocclusive pain crisis, or it can occur as a complication from a surgical procedure. As such, we should always be on the lookout for this entity whenever caring for patients with sickle cell disease. COVID-19 is a particular threat that can cause acute chest syndrome, which may require especially aggressive management (e.g. early exchange transfusion).
-
The IBCC chapter is located here.
- The podcast & comments are below.
Follow us on iTunes![](https://i0.wp.com/emcrit.org/wp-content/uploads/2016/11/apps.40518.14127333176902609.7be7b901-15fe-4c27-863c-7c0dbfc26c5c.5c278f58-912b-4af9-88f8-a65fff2da477.jpg?resize=100%2C100)
The Podcast Episode
Want to Download the Episode?
Right Click Here and Choose Save-As
- PulmCrit Wee: Rational selection of infusion rate based on loading dose - June 25, 2024
- PulmCrit: PPIs are safe and effective for GI prophylaxis… the end. - June 18, 2024
- PulmCrit: Bilevel Sequence Intubation (BSI) – The new standard - June 17, 2024
Dear Josh,
thanks a lot for all the great posts. You might have already noticed, but the units for the hemoglobin are wrong in the first part of the text (mg/dl instead of g/dl).
Best wishes,
Leo
Your thoughts on TPA for acute chest syndrome I had a physician recently order this vs exchange transfusion
[…] https://emcrit.org/pulmcrit/sickle-chest/ […]
[…] https://emcrit.org/pulmcrit/sickle-chest/ […]